| Robin S Gross, MD | |
|
Salem Hospital, 81 Highland Avenue, Salem, MA 01970 | |
| (978) 354-3500 | |
| Not Available |
| Full Name | Robin S Gross |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 31 Years |
| Location | Salem Hospital, Salem, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326155995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 153980 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
News Archive
The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.
Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.
› Verified 2 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.
Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robin S Gross, MD 9 Waldron Ct, Marblehead, MA 01945-3267 Ph: (978) 354-3500 | Robin S Gross, MD Salem Hospital, 81 Highland Avenue, Salem, MA 01970 Ph: (978) 354-3500 |
News Archive
The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.
Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.
› Verified 2 days ago
John A Michael, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 28 1/2 Broad St, Salem, MA 01970 Phone: 978-740-1878 | |
Dr. Lindsay K Fossett, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 81 Highland Ave, Salem Hospital Emergency Department, Salem, MA 01970 Phone: 978-354-3500 | |
Grace Taylor, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Dove Street, Salem, MA 01970 Phone: 978-741-1200 | |
Jenai E Beland Cohen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Salem Hospital, 81 Highland Avenue, Salem, MA 01970 Phone: 978-354-3500 | |
Thomas Edward Javery, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 35 Congress St, Salem, MA 01970 Phone: 678-825-7100 | |
Mohammed Saad Alkhafaji, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 81 Highland Ave, Salem, MA 01970 Phone: 978-741-1200 | |
Richard M Jackson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 81 Highland Ave, Salem, MA 01970 Phone: 978-741-1200 Fax: 978-740-4731 |